Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency

Journal of Human Hypertension volume 30, pages 463–466 (2016)Cite this article

Subjects

Abstract

The prevalence of malignant hypertension has clearly fallen with the advent of anti-hypertensive medication but has remained stable over the past 30–40 years in spite of progress in diagnosis and management of hypertension. A diagnosis of malignant hypertension is usually based on the association of severely elevated blood pressure with a Keith and Wagener stage III or IV retinopathy. We believe that this definition can be reconsidered for several reasons. Although simple and pragmatic, this definition corresponds to a time when there were few techniques for assessment of hypertensive target organ involvement, and does not take into account involvement of kidney, brain and heart; whereas the overall prognosis largely depends on how much they are affected. On the contrary, the acute blood pressure level and especially diastolic should not be a hard diagnostic criterion as it does not itself constitute the prognosis of the condition. We propose to consider that malignant hypertension with retinopathy is only one of a number of possible presentation(s) of acute hypertension with multi organ damage (hypertension multi organ damage (MOD)) and that the recognition of these hypertensive emergencies, when retinopathy is lacking, be based on acute elevation of BP associated with impairment of at least three different target organs. The objective of a new and expanded definition is to facilitate recognition of these true emergencies. The condition is more common than usually perceived and would have a much worse prognosis than the usual forms of hypertension. Early recognition and management of hypertension-MOD are fundamental to any improvement in prognosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Lip GY, Beevers M, Beevers DG . Do patients with de novo hypertension differ from patients with previously known hypertension when malignant phase hypertension occurs? Am J Hypertens 2000; 13: 934–939.

    Article  CAS  PubMed  Google Scholar 

  2. Ahmed ME, Walker JM, Beevers DG, Beevers M . Lack of difference between malignant and accelerated hypertension. Br Med J (Clin Res Ed) 1986; 292: 235–237.

    Article  CAS  Google Scholar 

  3. Gonzalez R, Morales E, Segura J, Ruilope LM, Praga M . Long-term renal survival in malignant hypertension. Nephrol Dial Transplant 2010; 25: 3266–3272.

    Article  PubMed  Google Scholar 

  4. Lip GY, Beevers M, Beevers DG . Does renal function improve after diagnosis of malignant phase hypertension? J Hypertens 1997; 15: 1309–1315.

    Article  CAS  PubMed  Google Scholar 

  5. Amraoui F, Van Der Hoeven NV, Van Valkengoed IG, Vogt L, Van Den Born BJ . Mortality and cardiovascular risk in patients with a history of malignant hypertension: a case-control study. J Clin Hypertens (Greenwich) 2014; 16: 122–126.

    Article  CAS  Google Scholar 

  6. Pak KJ, Hu T, Fee C, Wang R, Smith M, Bazzano LA . Acute hypertension: a systematic review and appraisal of guidelines. Ochsner J 2014; 14: 655–663.

    PubMed Central  PubMed  Google Scholar 

  7. Shantsila A, Shantsila E, Lip GY . Malignant hypertension: a rare problem or is it underdiagnosed? Curr Vasc Pharmacol 2010; 8: 775–779.

    Article  CAS  PubMed  Google Scholar 

  8. van den Born BJ, Koopmans RP, Groeneveld JO, van Montfrans GA . Ethnic disparities in the incidence, presentation and complications of malignant hypertension. J Hypertens 2006; 24: 2299–2304.

    Article  CAS  PubMed  Google Scholar 

  9. Lip GY, Beevers M, Beevers G . The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England. J Hypertens 1994; 12: 1297–1305.

    Article  CAS  PubMed  Google Scholar 

  10. Lane DA, Lip GY, Beevers DG . Improving survival of malignant hypertension patients over 40 years. Am J Hypertens 2009; 22: 1199–1204.

    Article  PubMed  Google Scholar 

  11. Leishman AW . Hypertension: treated and untreated; a study of 400 cases. Br Med J 1959; 1: 1361–1368.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lip GY, Beevers M, Beevers DG . Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens 1995; 13: 915–924.

    Article  CAS  PubMed  Google Scholar 

  13. Shantsila A, Lane DA, Beevers DG, Lip GY . Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study. J Hypertens 2012; 30: 974–979.

    Article  CAS  PubMed  Google Scholar 

  14. Pimenta E, Calhoun DA . Hypertensive crisis: forget the numbers. J Hypertens 2012; 30: 882–883.

    Article  CAS  PubMed  Google Scholar 

  15. Gosse P, Coulon P, Papaioannou G, Litalien J, Lemetayer P . Impact of malignant arterial hypertension on the heart. J Hypertens 2011; 29: 798–802.

    Article  CAS  PubMed  Google Scholar 

  16. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281–1357.

    Article  CAS  PubMed  Google Scholar 

  17. Lip GY, Beevers M, Dodson PM, Beevers DG . Severe hypertension with lone bilateral papilloedema: a variant of malignant hypertension. Blood Press 1995; 4: 339–342.

    Article  CAS  PubMed  Google Scholar 

  18. Amraoui F, van Montfrans GA, van den Born BJ . Value of retinal examination in hypertensive encephalopathy. J Hum Hypertens 2009; 4: 274–279.

    Google Scholar 

  19. Akoudad S, Portegies ML, Koudstaal PJ, Hofman A, van der Lugt A, Ikram MA et al. Cerebral microbleeds are associated with an increased risk of stroke: The Rotterdam Study. Circulation 2015; 132: 509–516.

    Article  PubMed  Google Scholar 

  20. Griffin KA, Polichnowski A, Litbarg N, Picken MA, Venkatachalam M, Bidani AK . Critical blood pressure threshold dependence of hypertensive injury and repair in a malignant Nephrosclerosis Model. Hypertension 2014; 64: 801–807.

    Article  CAS  PubMed  Google Scholar 

  21. van den Born BJ, Honnebier UP, Koopmans RP, van Montfrans GA . Microangiopathic hemolysis and renal failure in malignant hypertension. Hypertension 2005; 45: 246–251.

    Article  CAS  PubMed  Google Scholar 

  22. Shantsila A, Dwivedi G, Shantsila E, Butt M, Beevers DG, Lip GY . A comprehensive assessment of cardiac structure and function in patients with treated malignant phase hypertension: the West Birmingham Malignant Hypertension project. Int J Cardiol 2013; 167: 67–72.

    Article  PubMed  Google Scholar 

  23. van den Born BJ, Beutler JJ, Gaillard CA, de Gooijer A, van den Meiracker AH, Kroon AA . Dutch guideline for the management of hypertensive crisis–2010 revision. Neth J Med 2011; 69: 248–255.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology/Hypertension, University hospital of Bordeaux, Bordeaux, France

    A Cremer, S Rubin & P Gosse

  2. Department of vascular medicine, Academic Medical Centre, Amsterdam, The Netherlands

    F Amraoui & B J Van den Born

  3. University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK

    G Y H Lip

  4. Department of Nephrology. Hospital 12 de Octubre, Madrid, Spain

    E Morales & J Segura

Authors
  1. A Cremer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F Amraoui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Y H Lip
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E Morales
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Rubin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Segura
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B J Van den Born
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P Gosse
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P Gosse.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cremer, A., Amraoui, F., Lip, G. et al. From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency. J Hum Hypertens 30, 463–466 (2016). https://doi.org/10.1038/jhh.2015.112

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2015.112

This article is cited by

Search

Advanced search

Quick links